Resumen
Clinical metabolomics using stable isotope tracing represents an important new approach to obtaining metabolic parameters in human subjects in situ. In this chapter, the considerations for such clinical metabolomics are outlined and discussed. Descriptions include the essentials of patient accrual, permission, and institutional review approvals as well as specifics of treatments, tissue and biofluid collection, and curation. Although procedures vary among Institutes, the basic features for clinical research are common. Here, we illustrate the process from concept to analysis with an example from a recent study on non-small cell lung cancer metabolomics. This powerful new approach has already provided important new insights into metabolic adaptations in lung cancer cells.
| Idioma original | English |
|---|---|
| Título de la publicación alojada | The Handbook of Metabolomics |
| Editores | Teresa Whei-Mei Fan, Richard Higashi, Andrew Lane |
| Páginas | 29-60 |
| Número de páginas | 32 |
| DOI | |
| Estado | Published - 2012 |
Serie de la publicación
| Nombre | Methods in Pharmacology and Toxicology |
|---|---|
| Volumen | 17 |
| ISSN (versión impresa) | 1557-2153 |
| ISSN (versión digital) | 1940-6053 |
ODS de las Naciones Unidas
Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible
-
Good health and well being
ASJC Scopus subject areas
- General Pharmacology, Toxicology and Pharmaceutics
- Pharmacology (medical)
- Molecular Medicine
Huella
Profundice en los temas de investigación de 'Clinical aspects of metabolomics'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver